Sun, Rui
Wang, Kun
Yuan, Guoyue
Shi, Bimin
Wang, Xueying
Shao, Anna
Xu, Yulong
Wang, Qinghua
Ma, Jianhua
Funding for this research was provided by:
Innogen Pharmaceutical Co. Ltd.
Article History
Received: 29 September 2025
Accepted: 5 December 2025
First Online: 7 January 2026
Declarations
:
: Qinghua Wang is the founder, and Anna Shao and Yulong Xu are employees of Innogen Pharmaceutical Co., Ltd,. Rui Sun, Kun Wang, Guoyue Yuan, Binmin Shi, Xueying Wang and Jianhua Ma have nothing to disclose.
: This study was approved by ethics committees at all study sites and conducted according to the Declaration of Helsinki. The written informed consent was obtained from all participants. This trial has already been registered on the ClinicalTrials.gov: NCT06605287.